NCT05245786View on ClinicalTrials.gov

An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2022

Primary Completion Date

November 12, 2025

Study Completion Date

November 12, 2025

Conditions

Locally Advanced Rectal CarcinomaStage III Rectal Cancer AJCC v8Stage IIIA Rectal Cancer AJCC v8Stage IIIB Rectal Cancer AJCC v8Stage IIIC Rectal Cancer AJCC v8

Interventions

BIOLOGICAL

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A

Given IV

PROCEDURE

Imaging Technique

Undergo imaging

Trial Locations (1)

91010

RECRUITING

City of Hope Medical Center, Duarte

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER